Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Statement

3 Nov 2015 07:00

RNS Number : 2905E
Biome Technologies PLC
03 November 2015
 

03 November 2015

 

 

Biome Technologies plc

("Biome", the "Company" or the "Group")

 

Trading Update

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today publishes its trading update for the nine-month period ended 30 September 2015. 

Total Group revenues achieved in Q3 were ÂŁ1.3m, 169% ahead of the same quarter last year (2014: ÂŁ0.5m). This takes Group revenues for the nine months to 30 September 2015 to ÂŁ3.3m, 18% ahead of the prior year period (2014: ÂŁ2.8m).

The Group made a small profit before interest, tax, depreciation, amortisation, and share option charges in the third quarter (based on unaudited management accounts).

 

This performance meets one of the Group's long-term strategic KPIs, established in March 2014, of passing the 'earnings positive' inflexion point in quarterly trading during 2015.

The Group's cash position as at 30 September 2015 was ÂŁ1.7m (30 June 2015: ÂŁ1.8m).

Bioplastics Division

 

Revenues in the Bioplastics division in Q3 were ÂŁ0.5m (Q3 2014: ÂŁ0.1m) reflecting, amongst other factors, stability in the US single-serve coffee market compared to the downturn seen in the second half of 2014.

 

A new product line comprising temperature-tolerant materials suitable for injection moulding has reached commercialisation and first shipments were made during the quarter. Management expect that revenues from these products will build in the coming months.

 

To complement the division's existing product range, a further product is being developed for a non-woven biodegradable mesh suitable for liquid filtration. This product is in the process of being tested by several end customers with encouraging initial results.

 

Forward order visibility for the division is encouraging for the remainder of the year.

 

Stanelco RF Technologies Division

 

Revenues for Q3 in the RF Technologies division were ÂŁ0.8m (Q3 2014: ÂŁ0.4m). This year's orders and shipments are weighted towards the second half and this revenue growth includes elements of the recently announced ÂŁ1.1m contract to supply multiple furnaces, as well as progress on the contract announced last year to supply advanced analytical equipment to a UK regulated-industry sector.

 

Order levels within the division remain high with a substantial pipeline stretching beyond the remainder of the year and into 2016.

 

Outlook

 

Revenues and order flow in both divisions remain encouraging and the Board is now confident that Group revenues for the year ending 31 December 2015 will show a meaningful improvement against current market expectations, with a resultant reduced operating loss compared to these expectations.

 

Paul Mines, Chief Executive, said:

 

"Revenue generation is strong in both divisions and, coupling this with the achievement of a small group EBITDA profit in the quarter, we are increasingly confident that 2015 will become a very significant milestone in Biome's development."

 

 

- Ends -

 

 

 

For further information please contact:

 

Biome Technologies plc

 

Paul Mines, Chief Executive Officer

 

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

 

 

Allenby Capital

 

David Hart/Alex Brearley (Nominated Adviser)

Chris Crawford/Kelly Gardiner (Broker)

 

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

 

FTI Consulting

 

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDLLFBEFFLFBK
Date   Source Headline
2nd Jul 20087:00 amRNSTotal Voting Rights
16th Jun 20082:56 pmRNSHolding(s) in Company
16th Jun 20087:00 amRNSHolding(s) in Company
10th Jun 20085:36 pmRNSHolding(s) in Company
4th Jun 20087:00 amRNSAdditional Listing
14th May 20088:53 amRNSDirector/PDMR Shareholding
7th May 20089:51 amRNSDirectors Dealing
7th May 20087:00 amRNSLicense Agreement
1st May 20085:27 pmRNSDirector's Dealings
28th Apr 200811:56 amRNSResult of AGM
28th Apr 20087:00 amRNSAGM and IMS
25th Apr 20083:06 pmRNSDirector/PDMR Shareholding
7th Apr 20084:41 pmRNSSecond Price Monitoring Extn
7th Apr 20084:35 pmRNSPrice Monitoring Extension
7th Apr 20087:00 amRNSAnnual Information Update
2nd Apr 20087:00 amRNSPosting of Annual Report
14th Mar 20087:01 amRNSPreliminary Results
6th Mar 20082:35 pmRNSHolding(s) in Company
3rd Mar 20085:21 pmRNSHolding(s) in Company
29th Feb 20089:43 amRNSSpeculation re plastics
18th Feb 20084:40 pmRNSSecond Price Monitoring Extn
18th Feb 20084:35 pmRNSPrice Monitoring Extension
7th Feb 20084:13 pmRNSNotifiable Interest
4th Feb 200810:25 amRNSHolding(s) in Company
1st Feb 200811:40 amRNSHolding(s) in Company
30th Jan 20084:20 pmRNSNotifiable Interest
30th Jan 20087:01 amRNSNotifiable Interest
28th Jan 200811:22 amRNSNotifiable Interest
21st Jan 20083:27 pmRNSNotifiable Interest
17th Jan 20083:40 pmRNSNotifiable Interest
15th Jan 20084:40 pmRNSSecond Price Monitoring Extn
15th Jan 20084:35 pmRNSPrice Monitoring Extension
15th Jan 20082:28 pmRNSNotifiable Interest
14th Jan 20087:00 amRNSPre Close Update
9th Jan 20084:25 pmRNSHolding(s) in Company
4th Dec 20074:40 pmRNSSecond Price Monitoring Extn
4th Dec 20074:35 pmRNSPrice Monitoring Extension
26th Nov 20074:35 pmRNSPrice Monitoring Extension
25th Sep 20079:54 amRNSNotifiable Interest
10th Sep 20077:02 amRNSInterim Results
28th Aug 20072:33 pmRNSNotifiable Interest
30th Jul 20074:37 pmRNSNotifiable Interest
30th Jul 20074:35 pmRNSNotifiable Interest
27th Jul 20071:56 pmRNSNotifiable Interest
6th Jul 20077:01 amRNSTrading Statement
5th Jul 20076:19 pmRNSDirector Dealings
29th Jun 200712:26 pmRNSTotal Voting Rights
6th Jun 20074:14 pmRNSAdditional Listing
29th May 20075:29 pmRNSDisposal of Assets
29th May 20077:02 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.